AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
73 hedge funds and large institutions have $31.9M invested in AVEO Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 26
Holders
73
Holding in Top 10
–
Calls
$3.1M
Puts
$1.83M
Top Buyers
| 1 | +$2.91M | |
| 2 | +$2.31M | |
| 3 | +$1.09M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$732K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$380K |
Top Sellers
| 1 | -$3.5M | |
| 2 | -$1.18M | |
| 3 | -$322K | |
| 4 |
AIM
Assured Investment Management
New York
|
-$230K |
| 5 |
XSC
X-Square Capital
Guaynabo,
Puerto Rico
|
-$222K |